-+ 0.00%
-+ 0.00%
-+ 0.00%

PHARMING ANNOUNCES COMMERCIAL LAUNCH OF JOENJA (LENIOLISIB) IN JAPAN FOR ADULT AND PEDIATRIC PATIENTS WITH APDS AGED 4 AND OLDER

Reuters·08/13/2026 05:00:00

Please log in to view news